| IIRSX | VSCIX | IIRSX / VSCIX | |
| Total Expense Ratio | 0.43 | 0.04 | 1,075% |
| Annual Report Gross Expense Ratio | 0.56 | 0.04 | 1,400% |
| Fund Existence | 18 years | 28 years | - |
| Gain YTD | 1.929 | 9.858 | 20% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 334M | 163B | 0% |
| Annual Yield % from dividends | 1.39 | 1.33 | 104% |
| Returns for 1 year | 0.65 | 8.24 | 8% |
| Returns for 3 years | 18.27 | 44.96 | 41% |
| Returns for 5 years | -4.06 | 36.51 | -11% |
| Returns for 10 years | 11.10 | 143.93 | 8% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OIEFX | 24.30 | 0.11 | +0.45% |
| JPMorgan Equity Income R2 | |||
| FACTX | 58.01 | 0.24 | +0.42% |
| Fidelity Advisor Health Care M | |||
| LVOQX | 16.65 | 0.01 | +0.06% |
| Lord Abbett Value Opportunities R2 | |||
| FHESX | 13.85 | N/A | N/A |
| Federated Hermes SDG Engagement Eq IS | |||
| RAIRX | 28.68 | -0.01 | -0.03% |
| Manning & Napier Rainier Intl Discv Z | |||